Cargando…

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma

Serum monoclonal immunoglobulin (Ig) is the main diagnostic factor for patients with multiple myeloma (MM), however its prognostic potential remains unclear. On a large MM patient cohort (n = 4146), we observe no correlation between serum Ig levels and patient survival, while amount of intracellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vdovin, Alexander, Jelinek, Tomas, Zihala, David, Sevcikova, Tereza, Durech, Michal, Sahinbegovic, Hana, Snaurova, Renata, Radhakrishnan, Dhwani, Turi, Marcello, Chyra, Zuzana, Popkova, Tereza, Venglar, Ondrej, Hrdinka, Matous, Hajek, Roman, Simicek, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649770/ https://www.ncbi.nlm.nih.gov/pubmed/36357400 http://dx.doi.org/10.1038/s41467-022-34654-2

Ejemplares similares

PB2397: TRANSCRIPTOME ANALYSIS OF DIFFUSE LARGE B-CELL LYMPHOMA CELLS EXPRESSING MYD88 L265P REVEALS CD44, LGALS3, NFKBIZ AND BATF AS DOWNSTREAM TARGETS OF ONCOGENIC NF-ΚB SIGNALING.
por: Turi, Marcello, et al.
Publicado: (2023)

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling
por: Turi, Marcello, et al.
Publicado: (2023)

P805: EXTRAMEDULLARY MULTIPLE MYELOMA: MOLECULAR PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS
por: Zihala, David, et al.
Publicado: (2023)

Length-Dependent Translation Efficiency of ER-Destined Proteins
por: Sahinbegovic, Hana, et al.
Publicado: (2023)

Intercellular Mitochondrial Transfer in the Tumor Microenvironment
por: Sahinbegovic, Hana, et al.
Publicado: (2020)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
por: Celichowski, Piotr, et al.
Publicado: (2023)

A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
por: Motais, Benjamin, et al.
Publicado: (2020)

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma
por: Jelinek, Tomas, et al.
Publicado: (2023)

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
por: Zátopková, Martina, et al.
Publicado: (2022)

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
por: Motais, Benjamin, et al.
Publicado: (2021)

The Regulation and Double-Edged Roles of the Deubiquitinase OTUD5
por: Fu, Lin, et al.
Publicado: (2023)

OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase
por: Kim, Hyo Jin, et al.
Publicado: (2021)

Pleiotropic Roles of a KEAP1-Associated Deubiquitinase, OTUD1
por: Oikawa, Daisuke, et al.
Publicado: (2023)

Deubiquitinase OTUD3: a double-edged sword in immunity and disease
por: Xu, Qiao, et al.
Publicado: (2023)

The Deubiquitinase OTUD1 Suppresses Secretory Neutrophil Polarization And Ameliorates Immunopathology of Periodontitis
por: Song, Jia, et al.
Publicado: (2023)

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
por: Chyra Kufova, Zuzana, et al.
Publicado: (2018)

The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma
por: Xie, Peiyi, et al.
Publicado: (2021)

Analysis of deubiquitinase OTUD5 as a biomarker and therapeutic target for cervical cancer by bioinformatic analysis
por: Bai, Mixue, et al.
Publicado: (2020)

Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression
por: Hou, Tao, et al.
Publicado: (2022)

Deubiquitinase OTUD6A Regulates Innate Immune Response via Targeting UBC13
por: Li, Zhiwei, et al.
Publicado: (2023)

Proteasome-associated deubiquitinases and cancer
por: Mofers, Arjan, et al.
Publicado: (2017)

Current applications of multiparameter flow cytometry in plasma cell disorders
por: Jelinek, T, et al.
Publicado: (2017)

Current applications of multiparameter flow cytometry in plasma cell disorders
por: Jelinek, T, et al.
Publicado: (2018)

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma
por: Qiu, Shi, et al.
Publicado: (2022)

Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine
por: Hradská, Katarína, et al.
Publicado: (2022)

The deubiquitinase OTUD1 inhibits non‐small cell lung cancer progression by deubiquitinating and stabilizing KLF4
por: Ma, Xiaoyan, et al.
Publicado: (2022)

The deubiquitinase OTUD4 inhibits the expression of antimicrobial peptides in Paneth cells to support intestinal inflammation and bacterial infection
por: Yu, Keying, et al.
Publicado: (2023)

Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction
por: Wang, Feizuo, et al.
Publicado: (2023)

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
por: Chyra, Zuzana, et al.
Publicado: (2020)

A Cell Cycle-Regulated Toxoplasma Deubiquitinase, TgOTUD3A, Targets Polyubiquitins with Specific Lysine Linkages
por: Dhara, Animesh, et al.
Publicado: (2016)

Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission
por: Shi, Le, et al.
Publicado: (2020)

Deubiquitinase OTUD5 as a Novel Protector against 4‐HNE‐Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury
por: Liu, Lulu, et al.
Publicado: (2023)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins
por: Morrow, Marie E, et al.
Publicado: (2018)

Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
por: Moon, Seonghyeon, et al.
Publicado: (2021)

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Dudová, Lucie, et al.
Publicado: (2023)

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases
por: Sun, Chao, et al.
Publicado: (2014)

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
por: Liu, Ningning, et al.
Publicado: (2015)

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
por: Chen, Xin, et al.
Publicado: (2017)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_klbcj3l5oio8d6ttj8sfpag1af